Skip to main content
Caplight Logo









Stimuli Technology

Stimuli Technology

Private
Boulogne-BillancourtHealthcare & Life Scienceshttps://www.tensiplus.com/fr/

Last Round

Crowdfunding

Apr 28, 2021

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Stimuli Technology is a French MedTech company that develops and markets Tensi+, a non-invasive medical device for the treatment of overactive bladder using transcutaneous electrical nerve stimulation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

transcutaneous electrical nerve stimulationTENSposterior tibial nerve stimulationPTNSoveractive bladder treatmentmedtechhome-use medical deviceneuromodulationnon-invasive therapyurology devicebladder control devicemedical device rentalpelvic health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stimuli Technology Comparables

Compare Stimuli Technology with similar companies based on industry and business-model similarity.

Stimuli Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exodus Innovations
88%
Stimvia
85%
EBT Medical
83%

Stimuli Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingApr 28, 2021

Key People

Founding team and executive leadership

Delphine Agullo

CEO

Executive Team

Stimuli Technology Investors

Notable investors and investment history

Stimuli Technology investors
InvestorRounds
BpifranceCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 40% MoM.

Stimuli Technology Filings

Explore SEC and related filing metadata, where available.

Stimuli Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stimuli Technology's valuation, stock price, and market status.

Is Stimuli Technology a public or private company?

Stimuli Technology is a private company.

What is the current stock price of Stimuli Technology?

Stimuli Technology is a private company with no public stock price. Caplight tracks Stimuli Technology's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Stimuli Technology worth (valuation)?

Valuation information for Stimuli Technology is not publicly available.

Can I buy Stimuli Technology stock?

Stimuli Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stimuli Technology's last funding round?

Stimuli Technology's most recent funding round was Crowdfunding on April 28, 2021.

Who are the main investors in Stimuli Technology?

Key investors in Stimuli Technology include Bpifrance.

Will Stimuli Technology IPO soon?

No public IPO plans have been announced for Stimuli Technology.

How can I track Stimuli Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stimuli Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoulogne-Billancourt
Employee Range13
Year Founded2017
Last FundingApr 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?